Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Why I am over the moon about being a footie doctor

Q If TSH is rising but thyroxine is normal, what should I do?

A The persistently abnormal results exclude transient thyroid dysfunction. The hypothyroid phase of a thyroiditis should not last longer than a few weeks. An elevated TSH with normal thyroid hormone levels is sub-clinical hypothyroidism.

The decision to treat is based on the likelihood of conversion to frank hypothyroidism (more likely if the patient has a family history, a goitre or has detectable thyroid antibodies) and the probability that the patient will benefit from thyroxine replacement.

A trial of thyroxine would be reasonable for convincing hypothyroid symptoms, especially in the presence of the above associated factors.

But if the TSH is greater than 10miu/l then current consensus would be to start treatment, although evidence that symptoms improve is inconclusive.

There is no definitive data to suggest those with subclinical hypothyroidism (TSH<10miu )="" have="" any="" clear-cut="" benefit="" from="" thyroxine="" therapy,="" although="" some="" studies="" do="" show="" benefits="" on="" lipid="" profiles="" and="" psychometric="" function="" with="" a="" much="" lower="">

A progressive rise in TSH suggests they may develop frank hypothyroidism and treatment with thyroxine would be reasonable. Treatment goals are the same as frank hypothyroidism, ie, a TSH within the normal range, ideally close to 1miu/l.

Therapy should be reviewed and continued only in the presence of benefit. If thyroxine is not initiated then the thyroid function should be checked every three-six months.

Dr David Gable, specialist registrar, and Dr Steven Hurel, Consultant Endocrinologist, Department of Diabetes and Endocrinology,

University College Hospitals, London

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say